Roger Waltzman

Roger Waltzman

Company: Molecular Templates

Job title: Chief Medical Officer


Novel Immunotoxin MT-5111 in Avoiding Competition With & Overcoming the Primary Mechanisms of Tumor Resistance to Current HER2-Targeted Therapies 11:30 am

• Exploring the drug discovery process: target identification and validation, antitumor effect, pathway understanding, biomarkers • Discussing potential indications • Discussing the biomarker and patient status • Latest data and future directionsRead more

day: Day Two

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.